Bottle Label 15 mg (71610 0495 60)
Pioglitazone Tablet
Product Images NDC 71610-495
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 71610-495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)
The text describes figure 1 depicting the mean change from baseline for HbAlc in a 26-week placebo-controlled dose-ranging study, with observed values. The figure shows the mean at 0, 5, 10, 15, 20 weeks for three doses of drug, denoted as 15mg, 30mg, and 45mg. Therefore, the description could be something like "Figure 1 represents the mean change from baseline for HbAlc in a 26-week dose-ranging study, showing observed values for three doses of drug: 15mg, 30mg, and 45mg at different time points."*
Chemical Structure (Pioglitazone Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
